Summary: People with advanced cancer may experience a wide range of distressing and difficult-to-manage symptoms. MedCan 3 aims to reduce symptom burden in patients with advanced cancer by assessing the effect of escalating doses of THC/CBD 1:20 versus placebo on total symptom distress scores.
GP Requirements:
Referrers continue to provide normal clinical care
Trial staff prescribe, dispense drug & monitor patients